Recall
FDAHealthMarch 7, 2025

Mylan Institutional, Inc. — Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morga

⚠️ Super-Potent Drug: Out of specification potency results were obtained.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
March 7, 2025

Nationwide in the USA

What's affected?

Product
Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of 10 tablets each) per carton, Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 51079-445-20.
Lot code
3116074

Additional details

Lot 3116074, Exp. 09/30/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 347 Cartons.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.